Effects of BBB-permeable EGFR-TKI on neuropathic pain: Involvement of neuroinflammation

Effects of BBB-permeable EGFR-TKI on neuropathic pain: Involvement of neuroinflammation

碩士 === 國立陽明大學 === 藥理學研究所 === 106

Bibliographic Details
Main Authors:	Wen-Chien Ho, 何紋蒨
Other Authors:	Anya Maan-Yuh Lin
Format:	Others
Language:	zh-TW
Published:	2018
Online Access:	http://ndltd.ncl.edu.tw/handle/ee49u9

Similar Items

Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation
by: Yen-Ju Chen, et al.
Published: (2021-01-01)

Neuroinflammation in HIV-Related Neuropathic Pain
by: Huan-Jun Lu, et al.
Published: (2021-04-01)

BBB: Permeable Conjugate of Exogenic GABA
by: Qian Li, et al.
Published: (2017-08-01)

Effect of EGFR-TKI on Lymphangiogenesis of Lung Cancer with EGFR Mutation
by: Minghui CAI, et al.
Published: (2014-12-01)

Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain
by: Hari Prasad Joshi, et al.
Published: (2021-05-01)

An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain
by: Diana I Lurie
Published: (2018-08-01)

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain
by: Geeta Ramesh, et al.
Published: (2013-01-01)

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
by: Guo-Hao Xia, et al.
Published: (2014-12-01)

Use of fluorescent ANTS to examine the BBB-permeability of polysaccharide
by: Kevin Christopher, et al.
Published: (2015-01-01)

BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR.
by: Vishruti Makani, et al.
Published: (2016-01-01)

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant
by: Lihao Zhao, et al.
Published: (2019-12-01)

Treatment Choice After EGFR-TKI Resistance
by: Junling LI
Published: (2013-10-01)

Puerarin Alleviates Neuropathic Pain by Inhibiting Neuroinflammation in Spinal Cord
by: Ming Liu, et al.
Published: (2014-01-01)

Analysis of the pain and neuroinflammation after rats with neuropathic pain receive immunoglobulin intervention
by: Zhi-Sheng Lu1, et al.
Published: (2017-04-01)

The investigation of neuroprotective effect of EGFR-TKI: in vitro and in vivo studies
by: Wei-Zhong Zhao, et al.
Published: (2017)

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
by: Wenxian Wang, et al.
Published: (2019-02-01)

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
by: Jeng-Shiuan Tsai, et al.
Published: (2021-09-01)

EGFR and SOX2 crosstalk determines EGFR-TKI sensitivity and tumor progression
by: LEE, AN-CHUN, et al.
Published: (2018)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
by: Fu-Tsai Chung, et al.
Published: (2015-01-01)

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI
by: Yi SHAO, et al.
Published: (2020-05-01)

EGFR-TKI ADR Management Chinese Expert Consensus
by: Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
Published: (2019-02-01)

Epigenetic Modifications Associated to Neuroinflammation and Neuropathic Pain After Neural Trauma
by: Clara Penas, et al.
Published: (2018-06-01)

COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON NSLCLC PATIENTS WITH DISEASE PROGRESSION AND EGFR-TKI TREATMENT
by: Laksmi Wulandari, et al.
Published: (2017-12-01)

Novel Neurotrophic and Neuroprotective Properties of the BBB-permeable Polysaccharide, Midi-GAGR
by: Makani, Vishruti
Published: (2015)

Characterization of the Small Compounds -T315 on EGFR Degradation in EGFR-TKI Resistant Lung Adenocarcinoma
by: Kuo-Yen Huang, et al.
Published: (2015)

bbb
by: Chao-yi-han, et al.
Published: (2012)

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Qiang Wu, et al.
Published: (2021-04-01)

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
by: Tohru Ohmori, et al.
Published: (2021-01-01)

The Mechanism of Resistance to EGFR-TKI in NSCLC and Exploration to Overcome the Resistance
by: Baohui HAN, et al.
Published: (2009-12-01)

EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
by: Wu JX, et al.
Published: (2018-10-01)

Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
by: Danli Zhou, et al.
Published: (2019-04-01)

Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure
by: Kyoichi Kaira, et al.
Published: (2021-03-01)

Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability
by: Vieri Piazzini, et al.
Published: (2018-08-01)

Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)
by: Xin Li, et al.
Published: (2020-03-01)

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
by: Thang Thanh Phan, et al.
Published: (2019-01-01)

The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation
by: Wenbin Wan, et al.
Published: (2016-01-01)

EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
by: Xuan Zhu, et al.
Published: (2019-10-01)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
by: Qiming Wang, et al.
Published: (2019-06-01)

Treatment of Advanced NSCLC with Unknown EGFR Gene Status __ TKI or Chemotherapy?
by: Xiaoqing LIU, et al.
Published: (2014-10-01)

Advances in the Research of Autophagy in EGFR-TKI Treatment and Resistance  in Lung Cancer
by: Qicheng ZHANG, et al.
Published: (2016-09-01)